28/06/2019 Axbio Inc. developed a new technology for genetic sequencing, significantly ahead of the available analogues in such key parameters as price, accuracy and reading speed On June 28, 2019, AxBio Inc., represented in Russia by Generis Biotech, the...
Biosten, a Skolkovo resident startup, presented the technology of radiopaque coating based on lanthanum-containing microparticles at the Fundamental Research and Innovations for Endovascular Surgery 2018 conference on April 12. The event, organized by the N...
Quantitative modeling researchers from M&S Decisions, a Skolkovo member company, presented at a scientific seminar on innovative methods in drug development held on October 17, 2016 at the U.S. Food and Drug Administration (FDA) in Washington D.C. ...
International Conference Cell Technologies at the Edge: Research & Practice (CTERP 2016) has been scheduled to take place at Palace of Grand Duke Vladimir Alexandrovich, St. Petersburg, Russia, April 6-8, 2016. Recent discoveries in stem cell field,...
The Skolkovo Foundation will participate in 2014 BIO International Convention, the international biotechnology exhibition, which will take place in San Diego, USA on 23-26 June 2014. As the world’s largest biotechnology gathering BIO 2014 will bring together...
Since 3-5 June, 2014 in Finland (Turku city) was conducted Baltic Sea Health Summit – the biggest forum in pharmaceutical, biotechnology and medical industries in Baltic Sea countries ( www.bshs.eu ). The Health Forum was organized under the umbrella...
A resident of the Russian Innovation Center Skolkovo Hepatera is developing an innovative drug candidate - Myrcludex B - for treatment of chronic viral hepatitis B and D in close cooperation with the German biotech company MYR GmbH, a portfolio company of High...
OncoMax presented its research results at the 5 th European Multidisciplinary Meeting on Urological Cancers (EMUC) which was held in Marseille, France on 15-17 November 2013. Dr. Ilya Tsimafeyev, Scientific Advisor of Oncomax, won the First Prize for...
OncoMax presented the results of its research in the field of onco-urologic diseases at the 27 th Annual Congress of the European Association of Urologists taking place in Paris during February 24-28. Based on the research results measuring the effectiveness...
Bone Medical is pleased to announce that its BN006 programme for rheumatoid arthritis (RA) has been accepted as an innovation priority by The Skolkovo Foundation, the Russian government backed non-profit organization formed to stimulate the development of innovation...
Achildiev, Evgeny Rudolfovich Adrianov, Andrey Vladimirovich Agapov, Igor Ivanovich Ahmed, Niyaz Ahmedov, Shamil Dzhamanovich Akkola, Roberto Akchurin, Renat Suleymanovich Alekyan, Bagrat Geramovich Alyautdin, Renad Nikolayevich Andreev, Victor...
Email: Cluster-BMT@sk.ru
The cluster team consists of Russian and foreign specialists who have rich experience of working in venture businesses, including the work in leading investment Foundations, Russian institutes of development. The specialists’ competences cover the fields...
In Biomedicine: Molecular Medicine (genomics, proteomics, metabolomics); development of biomedical equipment; new-generation vaccines and systematic approaches to treating contagions; modern methods of medicinal drug delivery; cell technologies; immunology...
Biomedicine (genome and post-genome biomedical technologies, cell technologies, complex methods for diagnostics and treatment, biomedical equipment and materials), biopharmaceuticals (medicinal drugs), systemic bioinformatics, industrial biotechnologies.
The main strategic goal of the cluster is the creation of an ecosystem for sustaining and developing innovations in the field of biomedical technologies.
Eagle Genomics are conducting a second survey of current issues in operational bioinformatics. We build on the success of last year's survey which polled over 100 worldwide responses from both industry and academia. A report detailing the results of...
We are glad to announce that the Executive Committee of Federation of European Biochemical Societies (FEBS) has awarded the FEBS Congress for 2013 to the Russian Biochemical Society, President Professor Alexandre Gabibov . It will be located in St. Petersburg...
The Global Oncology Venture Event: Innovations in Cancer Research took place in Moscow on 28 September. The conference was dedicated to integrating Russian applied oncology research into the international community. Particular emphasis was placed on establishing...
On 20 September, the Skolkovo Foundation will organise a Friends of the Biomedical Technology Cluster Dinner at the Yusupov Palace as part of the 6th St Petersburg Scientific Forum, Physiology and Medicine of the 21st Century. In addition to Skolkovo Foundation...
The Skolkovo Fund has approved a $5m grant to TheraMAB, innovation and venture news source UNOVA reports. The money will be reportedly spent on development of a medicine that can selectively modulate activity of T-lymphocytes for treating rheumatoid arthritis...
By the end of this year, the Skolkovo Foundation plans to sign a cooperation agreement in biotechnology and medicine with the scientific centres of Siberian branches of the Russian Academy of Sciences (RAS) and Russian Academy of Medical Sciences (RAMS), federal...
The 6th St Petersburg Scientific Forum, Physiology and Medicine of the 21 st Century, will be held 19–23 September 2011 at the Scientific Center of the Russian Academy of Sciences (5 Universitetskaya Embankment). The Skolkovo Foundation will be its primary...
On 5–7 December, Skolkovo companies representing the biomedicine , IТ , energy efficiency clusters visited Berlin where they got acquainted with the innovation infrastructure. They visited the largest technopark Adlershof and the biomedical technopark...